International Union of Pharmacology. LIX. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Thyroid Hormone Receptors
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 58 (4) , 705-711
- https://doi.org/10.1124/pr.58.4.3
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Anti-thyroid hormonal activity of tetrabromobisphenol A, a flame retardant, and related compounds: Affinity to the mammalian thyroid hormone receptor, and effect on tadpole metamorphosisLife Sciences, 2005
- Thyroid hormone signaling is highly heterogeneous during pre- and postnatal brain developmentJournal of Molecular Endocrinology, 2004
- Selective activation of thyroid hormone signaling pathways by GC-1: a new approach to controlling cholesterol and body weightTrends in Endocrinology & Metabolism, 2004
- 2,3,7,8-tetrachlorodibenzo-p-dioxin augments the modulation of gene expression mediated by the thyroid hormone receptorToxicology and Applied Pharmacology, 2004
- Functional Evidence for Retinoid X Receptor (RXR) as a Nonsilent Partner in the Thyroid Hormone Receptor/RXR HeterodimerMolecular and Cellular Biology, 2002
- Desethylamiodarone interferes with the binding of co‐activator GRIP‐1 to the β1‐thyroid hormone receptorFEBS Letters, 2000
- Activation of the thyroid hormone receptor α gene promoter by the orphan nuclear receptor ERRαOncogene, 1998
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone α1-receptor proteinMolecular and Cellular Endocrinology, 1995
- Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone.Proceedings of the National Academy of Sciences, 1988